• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于青光眼治疗的马来酸噻吗洛尔眼用原位凝胶形成溶液的制剂与表征

Formulation and Characterization of Ophthalmic in Situ Gel Forming Solution of Timolol Maleate for Glaucoma.

作者信息

Rajagopal Kumaravelrajan, Kanmani Gokul, Venkatesan Suba, Palanivelu Amudha

机构信息

Department of Pharmaceutics, C.L. Baid Metha College of Pharmacy, The TN DR M.G.R. Medical University, Jothi Nagar, Thoraipakkam, Chennai, Tamil Nadu, India.

Department of Pharmacology, National Institute of Siddha, The TN DR.M.G.R.Medical University, Chennai, Tamil Nadu, India.

出版信息

Int J Pharm Compd. 2025 Mar-Apr;29(2):132-140.

PMID:40164064
Abstract

This study comprehensively investigates the physicochemical properties and performance of ophthalmic formulations containing timolol maleate with different polymers. Fourier-transform infrared (FTIR) spectroscopy revealed distinct spectral changes, indicating interactions between timolol maleate and Hydroxyethyl Cellulose (HEC), Xanthan gum, and Gellan gum. Clarity assessments confirmed transparency against white and black backgrounds. pH measurements ensured physiological compatibility (HEC: pH 6.90, Xanthan gum: pH 6.97, Gellan gum: pH 6.98). Evaluation of gelling capacity and strength highlighted Xanthan gum's superiority (Xanthan gum: 180 Pa, Gellan gum: 153 Pa). Viscosity studies demonstrated suitability for ocular use, with pre-gelling values of HEC: 100.11 cps, Xanthan gum: 112.55 cps, Gellan gum: 110.42 cps, and post-gelling values of HEC: 100.01 cps, Xanthan gum: 256.22 cps, Gellan gum: 206.21 cps. Osmolality aligned with ophthalmic norms (HEC: 272 mOsm/kg, Xanthan gum: 290 mOsm/kg, Gellan gum: 285 mOsm/kg). In vitro drug release profiles varied, with Xanthan gum showing sustained release (95.01% over 8 hours). Rabbit eye irritation studies confirmed safety. Stability assessments over three months validated consistent attributes, supporting their potential as effective ophthalmic formulations.

摘要

本研究全面调查了含有不同聚合物的马来酸噻吗洛尔眼科制剂的物理化学性质和性能。傅里叶变换红外(FTIR)光谱显示出明显的光谱变化,表明马来酸噻吗洛尔与羟乙基纤维素(HEC)、黄原胶和结冷胶之间存在相互作用。澄清度评估证实了在白色和黑色背景下的透明度。pH测量确保了生理相容性(HEC:pH 6.90,黄原胶:pH 6.97,结冷胶:pH 6.98)。胶凝能力和强度评估突出了黄原胶的优越性(黄原胶:180 Pa,结冷胶:153 Pa)。粘度研究表明其适合眼部使用,预胶凝值为HEC:100.11 cps,黄原胶:112.55 cps,结冷胶:110.42 cps,后胶凝值为HEC:100.01 cps,黄原胶:256.22 cps,结冷胶:206.21 cps。渗透压符合眼科标准(HEC:272 mOsm/kg,黄原胶:290 mOsm/kg,结冷胶:285 mOsm/kg)。体外药物释放曲线各不相同,黄原胶显示出缓释效果(8小时内释放95.01%)。兔眼刺激性研究证实了安全性。三个月的稳定性评估验证了其属性的一致性,支持它们作为有效眼科制剂的潜力。

相似文献

1
Formulation and Characterization of Ophthalmic in Situ Gel Forming Solution of Timolol Maleate for Glaucoma.用于青光眼治疗的马来酸噻吗洛尔眼用原位凝胶形成溶液的制剂与表征
Int J Pharm Compd. 2025 Mar-Apr;29(2):132-140.
2
Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.基于结冷胶和羟乙基纤维素的新型原位凝胶眼用给药系统:创新的流变学特征、体外和体内证据表明具有延长的角膜前滞留时间。
Int J Pharm. 2020 Jan 25;574:118734. doi: 10.1016/j.ijpharm.2019.118734. Epub 2019 Nov 6.
3
Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.采用 Box-Behnken 设计优化新型原位凝胶用于眼部药物缓释:体外、离体、体内和人体研究。
Int J Pharm. 2019 Jan 10;554:264-275. doi: 10.1016/j.ijpharm.2018.11.016. Epub 2018 Nov 10.
4
L-Carnosine: multifunctional dipeptide buffer for sustained-duration topical ophthalmic formulations.L-肌肽:用于长效局部眼科制剂的多功能二肽缓冲剂。
J Pharm Pharmacol. 2009 Jun;61(6):733-42. doi: 10.1211/jpp/61.06.0005.
5
Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide.基于纳米乳剂的电解质触发原位凝胶用于乙酰唑胺的眼部给药
Eur J Pharm Sci. 2017 Jun 15;104:302-314. doi: 10.1016/j.ejps.2017.04.013. Epub 2017 Apr 19.
6
Gellan gum-based in-situ gel formulations for ocular drug delivery: A practical approach.基于结冷胶的眼用药物递送原位凝胶制剂:一种实用方法。
Int J Biol Macromol. 2025 Feb;290:138979. doi: 10.1016/j.ijbiomac.2024.138979. Epub 2024 Dec 19.
7
Thiolated gellan gum/polyethylene glycol diacrylate hydrogels containing timolol maleate-loaded chitosan nanoparticles for ophthalmic delivery.含马来酸噻吗洛尔负载壳聚糖纳米粒的硫醇化结冷胶/聚乙二醇二丙烯酸酯水凝胶用于眼部给药。
Biomed Mater. 2025 Feb 21;20(2). doi: 10.1088/1748-605X/adb555.
8
Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.离子敏感型原位凝胶眼用给药系统的比较。第 1 部分:理化性质考察和体外释放。
Int J Pharm. 2011 Jun 15;411(1-2):69-77. doi: 10.1016/j.ijpharm.2011.03.042. Epub 2011 Mar 29.
9
Effect of gellan gum on the thermogelation property and drug release profile of Poloxamer 407 based ophthalmic formulation.结冷胶对泊洛沙姆407基眼用制剂的热凝胶化性质和药物释放曲线的影响。
Int J Biol Macromol. 2017 Sep;102:258-265. doi: 10.1016/j.ijbiomac.2017.03.194. Epub 2017 Apr 5.
10
Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation.布林佐胺二甲基亚砜原位凝胶眼用溶液:制剂优化及体外与体内评价。
AAPS PharmSciTech. 2020 Jan 16;21(2):69. doi: 10.1208/s12249-019-1555-0.